FNMA / FMCC
FNMA — —
FMCC — —
Entry $
Dark
GSE Feed
GSELoading headlines...
Market cap
—
Earnings × Multiple
Diluted shares
—
Post warrant exercise
Target price
—
Per share
Upside
—
vs entry
Model Inputs
Combined GSE earnings ($B) $25B
P/E multiple 15x
Base shares outstanding (B) 1.96B
Dilution % exercised 0%
Warrant ratio (dilution multiplier) 5x
Dilution Scenarios
Worst — max dilution
—
95% / 20-to-1 warrant
—
Base — 80% dilution
—
80% / 5x warrant
—
Best — no dilution
—
Common shareholders intact
—
Share price vs P/E multiple
Green = above entry  |  Red = below entry
Key Catalysts & Dates
Nov 2026Midterms — political pressure to act urgent
Sep 2025Warrant date expiration — Treasury deadline watch
Recap 2.5%Expected recapitalization rate for release target
FNMA ~2yrFannie Mae projected release timeline
FMCC ~2yrFreddie Mac projected release timeline
Jun 2026Bank capital levels may drop — accelerates path watch
Post capDividends enabled after capital levels met target
US Government Realized Value
SPS Earnings Growth (100% owed to Treasury)
Year 1—
Year 2—
Year 3—
Year 4—
USG holds senior preferred shares — 100% of GSE earnings owed back via SPS increase until capital levels are met. Strong gov incentive to release ASAP.
Thesis Summary
Bull case
GSEs earn $25B+/yr. At release, financial firms trade 15–20x. Even with 80% dilution, common stock has multi-bagger potential. Trump admin is motivated — releasing unlocks $300B+ for Treasury.
Bear case
Maximum 20-to-1 warrant exercise wipes common upside. Political gridlock delays exit indefinitely. Capital requirements could reduce distributable earnings. Congress could eliminate common equity.
Key variable
Dilution is everything. No-dilution target is ~$190/share at 15x; max-dilution lands ~$13/share. How warrants get exercised — and whether common holders get any concessions — is the whole game.
GSE News
Loading...
All
FNMA
FMCC
FHFA
Warrants
Fetching latest headlines...
GSE Trade Model — For informational purposes only. Not financial advice.
Model outputs depend on conservatorship terms, warrant exercise, capital requirements, and regulatory timelines.
0